NanoBio has partnered with BlueWillow Biologics to distribute the solution
DQE, partnering with BlueWillow Biologics, is now the healthcare and public safety distributor of the patented NanoBio Protect nasal antiseptic solution.
Healthcare and public safety workers are in constant contact with unknown pathogens out in our community, including COVID-19. Actions like frequent handwashing, wearing a protective mask, and using hand sanitizers are all important infection control practices that add layers of protection to prevent illness. The nose is a key entry point for most respiratory infections, so using a nasal antiseptic adds another layer of safety. Applied with a cotton nasal swab to the skin inside and around the nose, NanoBio Protect kills germs on contact and continues to kill germs for more than four hours after application.
Moisturizing and non-irritating, NanoBio Protect is safe for everyday use. NanoBio Protect’s active ingredient is benzalkonium chloride (BZK), a topical antiseptic approved by the FDA that has been safely used in over-the-counter antiseptic products for more than 75 years. NanoBio Protect’s patented nanotechnology places the BZK antiseptic on nano-droplets that are small enough to reach germs that hide in layers of skin, but big enough not to be absorbed through the skin into the body. Unlike other nasal sanitizers, NanoBio Protect is alcohol-free, so it does not dry out skin, which leads to irritation and cracking that can allow germs to enter.
Use NanoBio Protect every four to eight hours, as needed, in combination with other common protective measures, including handwashing, wearing a mask, and social distancing. Wearers include doctors, EMS professionals, firefighters, janitorial staff, nurses, retail clerks, teachers, and anyone who wants an extra layer of infection control protection.
